Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.16B |
| 2 |
Bank of America
BAC
|
+$855M |
| 3 |
Comcast
CMCSA
|
+$620M |
| 4 |
Amazon
AMZN
|
+$505M |
| 5 |
Micron Technology
MU
|
+$486M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Goldman Sachs
GS
|
+$441M |
| 2 |
Palo Alto Networks
PANW
|
+$300M |
| 3 |
Verizon
VZ
|
+$286M |
| 4 |
Fidelity National Information Services
FIS
|
+$285M |
| 5 |
Stanley Black & Decker
SWK
|
+$244M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 6.08% |
| 2 | Financials | 6.03% |
| 3 | Industrials | 5.01% |
| 4 | Consumer Discretionary | 4.73% |
| 5 | Healthcare | 4.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
451
PUT
RTX Corp
RTX
$297B
| $70.1M | 0.04% |
873,632
+55,933
| +7% | +$4.25M |
|
452
Take-Two Interactive
TTWO
$45.4B
| $70M | 0.04% |
637,512
-99,136
| -13% | -$10.8M |
|
453
PUT
AbbVie
ABBV
$441B
| $69.8M | 0.04% |
721,500
+100,300
| +16% | +$9.45M |
|
454
Regeneron Pharmaceuticals
REGN
$83B
| $69.6M | 0.04% |
185,086
+177,431
| +2,318% | +$71.9M |
|
455
CALL
Advanced Micro Devices
AMD
$801B
| $69.5M | 0.04% |
6,765,000
+4,485,400
| +197% | +$52.4M |
|
456
PUT
Mondelez International
MDLZ
$80.8B
| $69.5M | 0.04% |
1,622,700
+423,400
| +35% | +$17.8M |
|
457
CALL
ExxonMobil
XOM
$651B
| $69.4M | 0.04% |
830,100
-344,200
| -29% | -$28.5M |
|
|
XYZ
458
Block Inc
XYZ
$49.9B
| $69.1M | 0.04% |
+1,994,215
| New | +$73M |
|
459
CALL
iShares US Real Estate ETF
IYR
$4.58B
| $69.1M | 0.04% |
853,000
-341,400
| -29% | -$27.7M |
|
460
CALL
Qualcomm
QCOM
$173B
| $69M | 0.04% |
1,077,800
-529,900
| -33% | -$32.1M |
|
461
Dollar General
DG
$26.9B
| $69M | 0.04% |
741,654
+704,098
| +1,875% | +$60.5M |
|
462
PUT
American International
AIG
$39.8B
| $68.9M | 0.04% |
1,155,800
+632,700
| +121% | +$38.9M |
|
463
PUT
Texas Instruments
TXN
$251B
| $68.4M | 0.04% |
655,100
+282,900
| +76% | +$27.5M |
|
464
CALL
Target
TGT
$70.5B
| $68.3M | 0.04% |
1,046,200
-3,000
| -0.3% | -$181K |
|
465
CALL
DuPont de Nemours
DD
$19.4B
| $68.2M | 0.04% |
378,178
+194,835
| +106% | +$35.1M |
|
|
PPLI
466
People Inc
PPLI
$3.01B
| $67.9M | 0.04% |
3,105,065
-357,300
| -10% | -$8M |
|
467
Allstate
ALL
$65.4B
| $67.5M | 0.04% |
644,547
-903,983
| -58% | -$89M |
|
468
CALL
Bausch Health
BHC
$2.35B
| $67.4M | 0.04% |
3,245,300
+704,900
| +28% | +$11.2M |
|
469
CALL
Berkshire Hathaway Class B
BRK.B
$1.09T
| $67.4M | 0.04% |
340,100
-39,300
| -10% | -$7.46M |
|
|
ATVI
470
PUT
DELISTED
Activision Blizzard
ATVI
| $67.4M | 0.04% |
1,064,200
+298,300
| +39% | +$18.9M |
|
471
TechnipFMC
FTI
$30B
| $67.3M | 0.04% |
2,887,786
+550,042
| +24% | +$11.4M |
|
472
PG&E
PCG
$38.2B
| $67.3M | 0.04% |
1,500,463
+1,474,880
| +5,765% | +$82.6M |
|
473
Oshkosh
OSK
$9.37B
| $67M | 0.04% |
736,997
+687,620
| +1,393% | +$60.2M |
|
|
474
CALL
AbbVie
ABBV
$441B
| $67M | 0.04% |
692,600
-118,500
| -15% | -$11.2M |
|
|
CONE
475
DELISTED
CyrusOne Inc Common Stock
CONE
| $66.9M | 0.04% |
1,124,138
+899,877
| +401% | +$54.6M |
|
Similar funds
Ken Griffin's Q4 2017 Portfolio in Review
As of Q4 2017, Ken Griffin held 8,908 positions worth $164B, up 26% from $130B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Ken Griffin deployed $21.1B of net new capital in Q4 2017, opening 1,440 new positions and adding to 3,569 existing holdings. Its largest new stake was Celgene Corp: 3,708,916 shares worth $387M.
By sector, the portfolio is most concentrated in Technology at 6.1% of assets, down from 7% a quarter earlier, followed by Financials and Industrials.
On the sell side, the largest reduction was Goldman Sachs, an estimated $441M trimmed.
- Ken Griffin's largest Q4 2017 buy was Celgene Corp: 3,708,916 shares worth $387M.
- Ken Griffin added most to State Street SPDR S&P 500 ETF Trust in Q4 2017, an estimated $1.16B increase.
- Ken Griffin's biggest Q4 2017 reduction was Goldman Sachs, cutting an estimated $441M.
- Ken Griffin fully exited CR Bard Inc. in Q4 2017, selling an estimated $209M.
- Ken Griffin's ten largest holdings make up 19% of its $164B portfolio in Q4 2017.
- Ken Griffin opened 1,440 new positions and closed 988 in Q4 2017.
- Ken Griffin's portfolio value rose 26% quarter-over-quarter to $164B.
Based on Citadel Advisors's 13F filing for Q4 2017, filed 9 Feb 2018.